Posted on August 23, 2020 by Sitemaster
Two clinical trials have now confirmed the abscopal or bystander effect in prostate cancer. These effects occur when cancer cells that are not directly treated are nonetheless killed. … READ MORE …
Filed under: Drugs in development, Living with Prostate Cancer, Management, Treatment | Tagged: abscopal, bystander, castration-resistant, effect, metastatic, Treatment | 1 Comment »
Posted on October 17, 2018 by Sitemaster
Three new articles in the Journal of Oncology Practice take close look at the issue of risk/benefit and “value” in the management of prostate cancer today — and the management of advanced disease in particular. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: ADT, androgen, cardiocascular, cost, deprivation, effect, metabolic, outcome, sie, value | 7 Comments »
Posted on September 10, 2018 by Sitemaster
A newly published article in the Journal of Urology has indicated risk of an association between treatment with androgen deprivation therapy (ADT) and risk for a spectrum of liver disorders. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: ADT, adverse, andogen, deprivation, disease, effect, fatty, liver, NAFLD, nonalcoholic | 6 Comments »
Posted on January 10, 2018 by Sitemaster
A newly published paper in The Lancet Oncology has provided early data from the LATITUDE trial on patient-reported outcomes (PROs) and health-related quality of life (HRQoL) for men with newly diagnosed, high-risk, metastatic, castration-naive prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: adverse, effect, latitude, life, pain, quality, risk, trial | Leave a comment »
Posted on November 8, 2017 by Sitemaster
One of the annoyances associated with radiation treatments given over a long duration (for prostate cancer and for other reasons) is a growing feeling of fatigue. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: effect, exercise, fatigue, IMPACT, Management, radiation | 1 Comment »
Posted on September 24, 2015 by Sitemaster
Two recent papers have addressed evolution in our knowledge of the impact of androgen deprivation therapy (ADT) on various mental aspects of the health of patients with prostate cancer and their partners as well. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: ADT, androgen, deprivation, effect, IMPACT, mood, partner, patient, psychological | 3 Comments »
Posted on October 29, 2014 by Sitemaster
A newly published study in BJU International suggests (unsurprisingly) that androgen deprivation therapy (ADT) is associated with an increased risk of death among men with such cardiovascular conditions as congestive heart failure or prior heart attacks. … READ MORE …
Filed under: Living with Prostate Cancer, Management | Tagged: ADT, adverse, androgen, cardiac, deprivation, effect, heart, risk | 2 Comments »
Posted on January 3, 2013 by Sitemaster
Regular readers will be familiar with the fact that new drugs for prostate cancer are often tested against a “placebo.” They may also have heard the term “the placebo effect,” which generally implies that some interventions with no known (or theoretically possible) therapeutic benefit can be demonstrated to have a very real therapeutic effect. … READ MORE …
Filed under: Uncategorized | Tagged: effect, placebo | 7 Comments »
Posted on April 13, 2012 by Sitemaster
The U.S. Food & Drug Adminstration (FDA), yesterday, issued a statement about modifications to the labeling (the product prescribing information) for the two branded formulations of finasteride: Propecia® (finasteride 1 mg) and Proscar® (finasteride 5 mg). These modifications to the product labeling may be relevant to some men with or at risk for prostate cancer. … READ MORE …
Filed under: Uncategorized | Tagged: adverse, effect, finasteride, side | Leave a comment »
Posted on December 13, 2010 by Sitemaster
An article by a group of Romanian researchers published in October this year may have some controversial implications — so we want to be very clear that we don’t think too much should be read into it unless their data can be replicated by others. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: antiandrogen, bicalutamide, effect, orientation, sexual | Leave a comment »